Title of the centre:
WHO Collaborating Center for Reference and Research on Influenza
Director / Head:
Dr Dayan Wang
Institution:
Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention
Chinese Center for Disease Control and Prevention (China CDC)
Address:
155 Changbai Road, Changping District
102206
Town:
Beijing
Country:
CHINA
Region:
WPRO
Phone:
+86 10 5890 0851
Fax:
+86 10 5890 0851
Date of Designation:
28/Oct/2010
Last Redesignation:
28/Oct/2022
Expiry:
28/Oct/2026
Date of Discontinuation:
Terms of Reference:
- Under the coordination of WHO, to strengthen capacity to select and develop candidate vaccine viruses and make them timely available for vaccine development and production
- In support to WHO, to promote efforts on pandemic preparation and response, and providing findings and technical inputs.
- Under the guidance of WHO, to Share surveillance data with WHO and WHO Global Influenza Surveillance and Response System (GISRS) for both seasonal and novel influenza viruses.
- Upon WHO's request, to assist in the influenza surveillance strengthening in WHO Member States
- In support to WHO, to promote basic scientific research on influenza to support disease control and prevention
- Under WHO's leadership, contribute to the implementation of the WHO Pandemic influenza Preparedness (PIP) Framework, respecting rules set out by the PIP Framework for sharing of influenza viruses and access to vaccines and other benefits (http://www.who.int/influenza/pip/en/Framework) and to work under the Terms of Reference related to the work with Pandemic Influenza Preparedness biological materials as described in Annex 5 of the PIP Framework Document.
-
-
-
-
Types of activity:
- Provision of reference substances and other services
- Providing technical advice to WHO
- Product development (guidelines; manual; methodologies; etc.)
WHO Outputs:
| |
2.2.1 - Research agendas, predictive models and innovative tools, products and interventions available for high-threat health hazards |
| |
2.2.2 - Proven prevention strategies for priority pandemic-/epidemic-prone diseases implemented at scale |
| |
2.2.3 - Mitigate the risk of the emergence and re-emergence of high-threat pathogens |
Responsible Officer:
ZHANG Wenqing
Phone:
+41 22 791 4282
Technical Counterpart:
MATSUI Tamano
Phone:
+63 2 8 5289944
Access to annual progress reports and the current workplan (this is accessible to WHO Staff Members only):
Link to eWork
|